Related Experiment Videos
Anticancer drug activity in human bladder tumor cell lines
Abstract:
A panel of ten human bladder tumor cell lines were tested for drug sensitivity to ten standard or investigational anticancer drugs using a tumor colony assay. The activity of these anticancer agents in vitro was then compared with the clinical activity of these agents in bladder cancer. Drug activity was found in only five of the ten cell lines. In only 9 of 100 drug assays was the inhibition of colony growth lower than 30% of the controls. The activity of the more active anticancer drugs in bladder cancer (i.e., methotrexate and cisplatin) was not predicted using the tumor colony assay. Overall, the low level of activity of most anticancer drugs tested paralleled the clinical experience of drug resistance found in human bladder cancer.
Insights
This study evaluated anticancer drug effectiveness in bladder cancer cell lines using a tumor colony assay. The assay poorly predicted clinical outcomes, highlighting challenges in bladder cancer drug resistance.
Area of Science:
- Oncology
- Pharmacology
Background:
- Human bladder cancer exhibits significant resistance to standard and investigational anticancer drugs.
- Predictive assays are crucial for optimizing bladder cancer treatment strategies.
Purpose of the Study:
- To assess the in vitro efficacy of ten anticancer drugs across ten human bladder tumor cell lines.
- To compare the in vitro drug sensitivity data with known clinical activity in bladder cancer.
Main Methods:
- Utilized a tumor colony assay to evaluate drug sensitivity.
- Tested ten standard or investigational anticancer drugs.
- Compared in vitro results with established clinical outcomes in bladder cancer.
Main Results:
- Anticancer drug activity was observed in only five of the ten tested cell lines.
- Less than 10% of drug assays showed significant inhibition of colony growth (below 30% of controls).
- The tumor colony assay failed to accurately predict the clinical activity of known effective drugs like methotrexate and cisplatin.
Conclusions:
- The tumor colony assay demonstrated limited utility in predicting anticancer drug efficacy for bladder cancer.
- The poor in vitro activity observed mirrors the clinical challenges of drug resistance in human bladder cancer.
- Further development of predictive models is necessary for improving bladder cancer chemotherapy.